文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肿瘤坏死因子相关凋亡诱导配体、γ干扰素诱导蛋白 10 和 C 反应蛋白在预测 SARS-CoV-2 感染进展中的作用:一项前瞻性队列研究。

TNF-related apoptosis-inducing ligand, interferon gamma-induced protein 10, and C-reactive protein in predicting the progression of SARS-CoV-2 infection: a prospective cohort study.

机构信息

Centre for Infectious Diseases, Institute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany.

Department of Medicine V: Pneumology, Allergology and Intensive Care Medicine, ECLS Centre Saar, Saarland University Medical Centre, Saarland University, Homburg, Germany.

出版信息

Int J Infect Dis. 2022 Sep;122:178-187. doi: 10.1016/j.ijid.2022.05.051. Epub 2022 May 25.


DOI:10.1016/j.ijid.2022.05.051
PMID:35643306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9132472/
Abstract

BACKGROUND: Early prognostication of COVID-19 severity will potentially improve patient care. Biomarkers, such as TNF-related apoptosis-inducing ligand (TRAIL), interferon gamma-induced protein 10 (IP-10), and C-reactive protein (CRP), might represent possible tools for point-of-care testing and severity prediction. METHODS: In this prospective cohort study, we analyzed serum levels of TRAIL, IP-10, and CRP in patients with COVID-19, compared them with control subjects, and investigated the association with disease severity. RESULTS: A total of 899 measurements were performed in 132 patients (mean age 64 years, 40.2% females). Among patients with COVID-19, TRAIL levels were lower (49.5 vs 87 pg/ml, P = 0.0142), whereas IP-10 and CRP showed higher levels (667.5 vs 127 pg/ml, P <0.001; 75.3 vs 1.6 mg/l, P <0.001) than healthy controls. TRAIL yielded an inverse correlation with length of hospital and intensive care unit (ICU) stay, Simplified Acute Physiology Score II, and National Early Warning Score, and IP-10 showed a positive correlation with disease severity. Multivariable regression revealed that obesity (adjusted odds ratio [aOR] 5.434, 95% confidence interval [CI] 1.005-29.38), CRP (aOR 1.014, 95% CI 1.002-1.027), and peak IP-10 (aOR 1.001, 95% CI 1.00-1.002) were independent predictors of in-ICU mortality. CONCLUSIONS: We demonstrated a correlation between COVID-19 severity and TRAIL, IP-10, and CRP. Multivariable regression showed a role for IP-10 in predicting unfavourable outcomes, such as in-ICU mortality. TRIAL REGISTRATION: Clinicaltrials.gov, NCT04655521.

摘要

背景:对 COVID-19 严重程度进行早期预测可能会改善患者的护理。肿瘤坏死因子相关凋亡诱导配体(TRAIL)、γ-干扰素诱导蛋白 10(IP-10)和 C 反应蛋白(CRP)等生物标志物可能是用于即时检测和严重程度预测的潜在工具。

方法:在这项前瞻性队列研究中,我们分析了 COVID-19 患者的血清 TRAIL、IP-10 和 CRP 水平,将其与对照组进行比较,并研究了与疾病严重程度的相关性。

结果:共对 132 例患者的 899 项测量结果进行了分析(平均年龄 64 岁,40.2%为女性)。与健康对照组相比,COVID-19 患者的 TRAIL 水平较低(49.5 与 87pg/ml,P=0.0142),而 IP-10 和 CRP 水平较高(667.5 与 127pg/ml,P<0.001;75.3 与 1.6mg/l,P<0.001)。TRAIL 与住院和重症监护病房(ICU)停留时间、简化急性生理学评分 II 和国家早期预警评分呈负相关,而 IP-10 与疾病严重程度呈正相关。多变量回归显示肥胖(调整后的优势比[aOR] 5.434,95%置信区间[CI] 1.005-29.38)、CRP(aOR 1.014,95% CI 1.002-1.027)和峰值 IP-10(aOR 1.001,95% CI 1.00-1.002)是 ICU 死亡率的独立预测因素。

结论:我们证明了 COVID-19 严重程度与 TRAIL、IP-10 和 CRP 之间存在相关性。多变量回归显示 IP-10 在预测不良结局(如 ICU 死亡率)方面具有作用。

临床试验注册:Clinicaltrials.gov,NCT04655521。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/888f07341124/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/6f863c7e9ceb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/2f3e243d0d41/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/e4d7c5ec62c5/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/9832036689fd/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/54d64aae709a/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/888f07341124/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/6f863c7e9ceb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/2f3e243d0d41/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/e4d7c5ec62c5/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/9832036689fd/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/54d64aae709a/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5251/9132472/888f07341124/gr6_lrg.jpg

相似文献

[1]
TNF-related apoptosis-inducing ligand, interferon gamma-induced protein 10, and C-reactive protein in predicting the progression of SARS-CoV-2 infection: a prospective cohort study.

Int J Infect Dis. 2022-9

[2]
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia.

Cytokine. 2023-2

[3]
Evaluating TRAIL and IP-10 alterations in vaccinated pregnant women after COVID-19 diagnosis and their correlation with neutralizing antibodies.

Front Immunol. 2024

[4]
Identifying patients with bacterial infections using a combination of C-reactive protein, procalcitonin, TRAIL, and IP-10 in the emergency department: a prospective observational cohort study.

Clin Microbiol Infect. 2018-9-28

[5]
Association of viral load with TRAIL, IP-10, CRP biomarker signature and disease severity in children with respiratory tract infection or fever without source: A prospective, multicentre cohort study.

J Med Virol. 2023-1

[6]
Temporal Dynamics of Host Immune Response Associated With Disease Severity and Time to Recovery in Patients Hospitalized for COVID-19.

Crit Care Explor. 2022-9-7

[7]
Combinatorial Host-Response Biomarker Signature (BV Score) and Its Subanalytes TRAIL, IP-10, and C-Reactive Protein in Children With Mycoplasma pneumoniae Community-Acquired Pneumonia.

J Infect Dis. 2024-8-16

[8]
Natural variability of TRAIL, IP-10, and CRP in healthy adults - The "HERACLES" study.

Cytokine. 2024-4

[9]
Expression of TRAIL, IP-10, and CRP in children with suspected COVID-19 and real-life impact of a computational signature on clinical decision-making: a prospective cohort study.

Infection. 2023-10

[10]
TRAIL and IP-10 dynamics in pregnant women post COVID-19 vaccination: associations with neutralizing antibody potency.

Front Cell Infect Microbiol. 2024

引用本文的文献

[1]
mRNA Vaccination for COVID-19 Lowers the Risk for Pulmonary Fibrosis Through GIP-10/Gal-3/HIF-1 Downregulation.

Cureus. 2025-5-17

[2]
Early Immunological and Inflammation Proteomic Changes in Elderly COVID-19 Patients Predict Severe Disease Progression.

Biomedicines. 2025-5-10

[3]
Cytokine Profile Analysis During Sialodacryoadenitis Virus and Mouse Hepatitis Virus JHM Strain Infection in Primary Mixed Microglia and Astrocyte Culture-Preliminary Research.

Cells. 2025-4-25

[4]
OPG and BAFF as predictive biomarkers of the severity of SARS-CoV-2 infection.

J Cell Mol Med. 2025-2

[5]
Evaluating TRAIL and IP-10 alterations in vaccinated pregnant women after COVID-19 diagnosis and their correlation with neutralizing antibodies.

Front Immunol. 2024

[6]
Multiplex array analysis of circulating cytokines and chemokines in COVID-19 patients during the first wave of the SARS-CoV-2 pandemic in Milan, Italy.

BMC Immunol. 2024-7-26

[7]
Serum cytokine dysregulation signatures associated with COVID-19 outcomes in high mortality intensive care unit cohorts across pandemic waves and variants.

Sci Rep. 2024-6-13

[8]
Predictive biomarkers of COVID-19 prognosis identified in Bangladesh patients and validated in Japanese cohorts.

Sci Rep. 2024-6-3

[9]
Demystifying COVID-19 mortality causes with interpretable data mining.

Sci Rep. 2024-5-2

[10]
TRAIL and IP-10 dynamics in pregnant women post COVID-19 vaccination: associations with neutralizing antibody potency.

Front Cell Infect Microbiol. 2024

本文引用的文献

[1]
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study.

Clin Microbiol Infect. 2022-5

[2]
CRP, SAA, LDH, and DD predict poor prognosis of coronavirus disease (COVID-19): a meta-analysis from 7739 patients.

Scand J Clin Lab Invest. 2021-12

[3]
Hospitalisation among vaccine breakthrough COVID-19 infections.

Lancet Infect Dis. 2021-11

[4]
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19.

Sci Transl Med. 2021-9-22

[5]
Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study.

Emerg Med J. 2021-7

[6]
Novel SARS-CoV-2 variants: the pandemics within the pandemic.

Clin Microbiol Infect. 2021-8

[7]
COVID-19: fighting the foe with Virchow.

Infection. 2021-10

[8]
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.

J Exp Med. 2021-7-5

[9]
Interleukin-6 blocking agents for treating COVID-19: a living systematic review.

Cochrane Database Syst Rev. 2021-3-18

[10]
Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review.

Cytokine. 2021-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索